Gritstone to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Gritstone bio, a clinical-stage biotechnology company (Nasdaq: GRTS), announced participation in two investor conferences. The 5th Annual Evercore ISI HealthCONx Conference is scheduled for November 29, 2022, featuring CEO Andrew Allen in a virtual fireside chat. The 34th Annual Piper Sandler Healthcare Conference will take place on December 1, 2022, with CFO Celia Economides and CBO Matthew J. Hawryluk presenting in New York. Live webcasts will be available for both events, and archived replays will be accessible for 30 days afterwards.

EMERYVILLE, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that Gritstone management will participate in the following upcoming investor conferences.

5^th Annual Evercore ISI HealthCONx Conference
Fireside Chat Date and Time: Tuesday, November 29, 2022 at 10:30am EST
Presenter: Andrew Allen, M.D., Ph.D., Co-founder, President, and Chief Executive Officer
Location: Virtual
Webcast: https://wsw.com/webcast/evercore29/grts/2400960

34^th Annual Piper Sandler Healthcare Conference
Fireside Chat Date and Time: Thursday, December 1, 2022 at 2:30pm EST
Presenter: Celia Economides, Chief Financial Officer and Matthew J. Hawryluk, Chief Business Officer
Location: New York, NY
Webcast: https://event.webcasts.com/starthere.jsp?ei=1582550&tp_key=0164d9de42

The presentations can be viewed live via the Investors & Media section of Gritstone’s website at https://ir.gritstonebio.com/investors/events. An archived replay will be accessible for 30 days following the event.

About Gritstone bio
Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to create the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio of product candidates to treat and prevent viral diseases and solid tumors in pursuit of improving patient outcomes and eliminating disease. www.gritstonebio.com

Gritstone Contacts
Investors:
George E. MacDougall
Director, Investor Relations & Corporate Communications
Gritstone bio
ir@gritstone.com

Media:
Dan Budwick
1AB
(973) 271-6085
dan@1abmedia.com

FAQ

What are the details of the Gritstone bio investor conference on November 29, 2022?

Gritstone bio will participate in the 5th Annual Evercore ISI HealthCONx Conference with a fireside chat hosted by CEO Andrew Allen at 10:30 AM EST on November 29, 2022.

When is the Piper Sandler Healthcare Conference where Gritstone bio will present?

Gritstone bio will present at the 34th Annual Piper Sandler Healthcare Conference on December 1, 2022, at 2:30 PM EST in New York.

How can I watch the Gritstone bio investor conference presentations?

The presentations can be viewed live through Gritstone bio’s website in the Investors & Media section, with archived replays available for 30 days after the events.

Who will represent Gritstone bio at the upcoming investor conferences?

CEO Andrew Allen will represent Gritstone bio at the Evercore ISI HealthCONx Conference, while CFO Celia Economides and CBO Matthew J. Hawryluk will present at the Piper Sandler Healthcare Conference.